Ramesh Subrahmanian
About Ramesh Subrahmanian
Data last updated:
Ramesh Subrahmanian is a Director at Laurus Labs Limited (since 2024) and Director at Integris Medtech Limited (since 2025). The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹8,827 Cr; the largest is Laurus Labs Limited at ₹6,868 Cr (FY 2026). Earlier, Ramesh Subrahmanian was an Additional Director at Healthium Medtech Limited (2021) and Additional Director at Organon (India) Private Limited (2010) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Laurus Labs Limited L24239AP2005PLC047518 | Director | 25 Jul 2024 | 2005 | ₹6,868 Cr (FY 2026) | Active |
 Integris Medtech Limited U85110DL2008PLC177230 | Director | 01 Aug 2025 | 2008 | ₹1,960 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Healthium Medtech Limited U03311KA1992PLC013831 | Additional Director | 17 Aug 2021 | 1992 | ₹870 Cr (FY 2025) | Active |
 Organon (India) Private Limited U24231MH1967PTC187949 | Additional Director | 02 Feb 2010 | 1967 | ₹135 Cr (FY 2025) | Active |
 Fulford (India) Private Limited U99999MH1948PTC006199 | Director | 26 Apr 2010 | 1948 | ₹95.86 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ramesh Subrahmanian
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramesh Subrahmanian
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramesh Subrahmanian
Ramesh Subrahmanian currently holds 2 directorships: Laurus Labs Limited (Director, since 25 Jul 2024, revenue ₹6,868 Cr (FY 2026)); Integris Medtech Limited (Director, since 01 Aug 2025, revenue ₹1,960 Cr (FY 2025)).
Ramesh Subrahmanian was first appointed on 02 Feb 2010 as Additional Director at Organon (India) Private Limited. The most recent appointment on record is 01 Aug 2025 at Integris Medtech Limited.
The 2 current companies of Ramesh Subrahmanian that report revenue have a combined latest revenue of ₹8,827 Cr: Laurus Labs Limited ₹6,868 Cr (FY 2026); Integris Medtech Limited ₹1,960 Cr (FY 2025).
Ramesh Subrahmanian held 3 earlier board appointments: Healthium Medtech Limited (Additional Director, 17 Aug 2021 to 17 Aug 2021); Organon (India) Private Limited (Additional Director, 02 Feb 2010 to 26 Apr 2010); Fulford (India) Private Limited (Director, 26 Apr 2010 to 31 May 2011).
The current boards of Ramesh Subrahmanian's companies include Krishna Chaitanya Chava (Laurus Labs Limited), Ravindranath Kancherla (Laurus Labs Limited), Satyanarayana Chava (Laurus Labs Limited), Satyanarayana Chava (Laurus Labs Limited), Sekar Karnam (Laurus Labs Limited), Shekhar Chintamani Mande (Laurus Labs Limited), among others.